Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies
- Written by PR Newswire
![]() |
SEOUL, South Korea, May 26, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 30–June 3 in C...
Read more: Lunit Highlights AI's Role in Advancing Precision Oncology at ASCO 2025 with 12 Studies















